News > Unternehmensnachrichten > Affymax to Present at BIO CEO and ... - Ad-Hoc-News (Pressemitteilung) PDF Print

Affymax?s product candidate, Hematide?, is currently in Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure. ...

read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.